ArticleOncotarget2018

Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential.

Jing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.